Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John M Fitzpatrick

Showing results (81-90 of 171) with videos related to

Pageof 18
Sort By:
BJU International|March 30, 2005
An evidence-based approach to understanding the pharmacological class effect in the management of prostatic diseasesChristopher P Evans, Neil Fleshner, John M Fitzpatrick, et al.
BJU International|March 24, 2009
Prostate cancer: a serious disease suitable for preventionJohn M Fitzpatrick, Claude Schulman, Alexandre R Zlotta, et al.
Clinical Science (London, England : 1979)|September 24, 2004
Prostate epithelial cell differentiation and its relevance to the understanding of prostate cancer therapiesRonan M Long, Colm Morrissey, John M Fitzpatrick, et al.
BJU International|January 12, 2012
PCA: prostate cancer, patient-centred approach or both?Louis Denis, Steven Joniau, Alberto Bossi, et al.
The Oncologist|February 19, 2014
In replyAxel S Merseburger, Joaquim Bellmunt, Cheryl Jenkins, et al.
Journal of the American College of Surgeons|July 28, 2004
Critical involvement of stress-activated mitogen-activated protein kinases in the regulation of intracellular adhesion molecule-1 in serosal fibroblasts isolated from patients with Crohn's diseaseDavid J Beddy, William R Watson, John M Fitzpatrick, et al.
The Oncologist|May 15, 2013
Perspectives on treatment of metastatic castration-resistant prostate cancerAxel S Merseburger, Joaquim Bellmunt, Cheryl Jenkins, et al.
BJU International|February 16, 2011
Epstein criteria for insignificant prostate cancerSheng F Oon, R William Watson, John J O'Leary, et al.
BJU International|June 14, 2008
Progression of benign prostatic hyperplasia: systematic review of the placebo arms of clinical trialsMark Emberton, John M Fitzpatrick, Manuel Garcia-Losa, et al.
BJU International|July 2, 2011
Prevention and management of haematomata after minimally invasive radical prostatectomyRoger Kirby, Ben Challacombe, Krishna Patil, et al.
Pageof 18

Showing results (81-90 of 171) with videos related to

Sort By:
Pageof 18
BJU International|March 30, 2005
An evidence-based approach to understanding the pharmacological class effect in the management of prostatic diseasesChristopher P Evans, Neil Fleshner, John M Fitzpatrick, et al.
BJU International|March 24, 2009
Prostate cancer: a serious disease suitable for preventionJohn M Fitzpatrick, Claude Schulman, Alexandre R Zlotta, et al.
Clinical Science (London, England : 1979)|September 24, 2004
Prostate epithelial cell differentiation and its relevance to the understanding of prostate cancer therapiesRonan M Long, Colm Morrissey, John M Fitzpatrick, et al.
BJU International|January 12, 2012
PCA: prostate cancer, patient-centred approach or both?Louis Denis, Steven Joniau, Alberto Bossi, et al.
The Oncologist|February 19, 2014
In replyAxel S Merseburger, Joaquim Bellmunt, Cheryl Jenkins, et al.
Journal of the American College of Surgeons|July 28, 2004
Critical involvement of stress-activated mitogen-activated protein kinases in the regulation of intracellular adhesion molecule-1 in serosal fibroblasts isolated from patients with Crohn's diseaseDavid J Beddy, William R Watson, John M Fitzpatrick, et al.
The Oncologist|May 15, 2013
Perspectives on treatment of metastatic castration-resistant prostate cancerAxel S Merseburger, Joaquim Bellmunt, Cheryl Jenkins, et al.
BJU International|February 16, 2011
Epstein criteria for insignificant prostate cancerSheng F Oon, R William Watson, John J O'Leary, et al.
BJU International|June 14, 2008
Progression of benign prostatic hyperplasia: systematic review of the placebo arms of clinical trialsMark Emberton, John M Fitzpatrick, Manuel Garcia-Losa, et al.
BJU International|July 2, 2011
Prevention and management of haematomata after minimally invasive radical prostatectomyRoger Kirby, Ben Challacombe, Krishna Patil, et al.
Pageof 18